DECN Press Release dated August 7, 2018 – “DECN Makes Its Mark In $1+ Billion Dollar Pet Diabetes & Glucose Testing Market With Two New Products, Petsure! & Petultimate!”
“The company separately has announced that it has entered into distribution agreements with distributors for big box pet stores for its PetSure! product line. Shipping to "big box" is anticipated to commence in October 2018.”
- What BIG BOX was this product line shipped to?
- What % of the $1+ Billion Dollar Pet Diabetes & Glucose Testing Market has DECN captured since 2018?
As a matter of FACT, here are A FEW other Press Release statements from DECN 2017-18, what IF ANYTHING has become reality, i.e. ACTUAL manufacture, orders, sales?
JUDGE FOR YOURSELF!
LOS ANGELES, CA / ACCESSWIRE / August 24, 2017 / Decision Diagnostics Corp. (OTC PINK: DECN), a manufacturer, quality plan administrator, and exclusive worldwide sales, service, and regulatory process agent for GenUltimate!™ glucose test strips, the pre-market ready GenSure!™, to be launched in International markets on September 5, 2017 ……
PR 1/2/18 - 2018 is expected to become a seminal year for DECN. It begins with the marketing of its launched GenSure!™ diabetic test strip, targeted for the patient population across the developing markets. … This intense activity begins January 15, 2018 with the global introduction of the GenSure!™ test strip.
DECN Anticipates Initial International Sales of 165,000 Genchoice! Boxes Per Month as it also Readies Panacea Genprecis! System, and as Hybrid Private Label Plan Reaches Intensity
PR 3/13/18 - Mr. Berman continued, "DECN anticipates the GenChoice! introduction to International markets in June 2018 as a prelude to the eventual U.S. introduction. It is believed that GenChoice! will contribute $100 million in annual revenues per our pro forma financial forecast. As such, GenChoice! will temporarily become DECN's largest tertiary revenue producer and should post margins in excess of the company's successful GenUltimate! test strips, that is until our panacea product GenPrecis!, reaches the same stage of market-readiness in the next several weeks."
